A neomorphic protein interface catalyzes covalent inhibition of RAS <sup>G12D</sup> aspartic acid in tumorsCaroline E. Weller, David Wildes, Abby Marquez et al.|Science|2025Cited by 31
Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinomaUrszula N. Wasko, Kenneth P. Olive, Jingjing Jiang et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 11
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapyMallika Singh, David Wildes, Matthew Holderfield et al.|Research Square|2023Cited by 5
Abstract 5507: Mechanisms of resistance to RAS-GTP inhibition in pancreatic cancerJoshua H. Choe, Andrew J. Aguirre, Julien Dilly et al.|Cancer Research|2025Cited by 2
Abstract 1927: Resistance to RAS-GTP inhibition in models of pancreatic ductal adenocarcinoma arises downstream of RAS effectorsUrszula N. Wasko, Kenneth P. Olive, Jingjing Jiang et al.|Cancer Research|2024Cited by 0